Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes

Conclusions/interpretationDetection of GADA by ECL assay, given technical advantages over RBA-GADA, identified adult-onset diabetes patients at higher risk of requiring early insulin treatment, as did clinical phenotype, together allowing for more accurate clinical diagnosis and management.Graphical abstract

http://link.springer.com/10.1007/s00125-021-05492-6

Source: Diabetologia - August 24, 2021 Category: Endocrinology Source Type: research